Today, we’re celebrating #WomensEqualityDay by recognizing the powerful contributions of the women in our organization. Their impact is felt throughout our workplace and in the communities where we work and live. #BelongAtAbbVie [Video description: An animated photo collage of women at AbbVie. On-screen text reads, "Happy Women's Equality Day to all the women helping us make a remarkable impact."]
Perihal kami
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Laman web
-
http://www.abbvie.com
Pautan luaran untuk AbbVie
- Industri
- Pembuatan Farmaseutikal
- Saiz syarikat
- 10,001+ pekerja
- Ibu pejabat
- North Chicago, Illinois
- Jenis
- Syarikat Awam
- Pengkhususan
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, Eye Care
Lokasi
Pekerja di AbbVie
Kemas Kini
-
Following the European Commission’s conditional marketing authorization in relapsed/refractory follicular #lymphoma, in partnership with Genmab, Jacqueline Nielsen, Ph.D., Therapeutic Head, Hematology at AbbVie, shares the importance of this milestone for #BloodCancer patients. Explore our research in #oncology: https://bit.ly/4cAoB71 [Image description: Jacqueline Nielsen, Ph.D., Therapeutic Head, Hematology, AbbVie, says, “This milestone advances our commitment to elevating care for people living with cancer.”]
-
-
Proud to announce we've received a top score on this year's Inclusion Index from Seramount for fostering a workplace culture that encourages diversity, inclusion and employee growth. Read more: https://bit.ly/46QrHCt #BelongAtAbbVie #InclusionIndex2024
-
-
JUST IN: The European Commission has granted conditional marketing authorization in relapsed/refractory follicular #lymphoma, a form of #BloodCancer, after two or more lines of prior therapy, developed in collaboration with Genmab. Read more: https://bit.ly/3AyFvWb [Video description: On-screen text reads, “Oncology News.”]
-
Join us in congratulating Tim Richmond, our executive vice president and chief human resources officer, on receiving the HR Division - Academy of Management's 2024 "Distinguished HR Executive Award" for his #leadership in advancing the #HumanResources management field. This award highlights Tim’s contributions to the HR practice, including his ongoing support of HR research and education. As a member of our executive leadership team, Tim and the HR team he leads enable our growth and help make us one of the world’s best workplaces.
-
-
Earlier this year, our employees across the globe participated in AbbVie In Motion, our annual team-based movement and activity challenge. See how we make employee health and well-being one of our top priorities: https://bit.ly/3yzcby5 #AbbVieLife [Video description: Images and statistics recapping the impact of AbbVie in Motion around the world, including 16K+ participants; 1,400+ teams from 69 countries; more than 25M total physical activity minutes logged.]
-
Thank you to our 13,000+ employees who served their local #communities during Week of Possibilities, the AbbVie Foundation’s annual #volunteer event. Together they spent nearly 50,000 hours contributing to numerous community projects around the globe, including renovating and improving schools, serving meals, building homes, cleaning up waterways and more. See the full impact of their volunteering: https://bit.ly/4dyXFoQ #AbbVieGivesBack [Video description: Interviews with AbbVie employees talking about volunteering during Week of Possibilities and footage of volunteer activities.]
-
How long does it take to bring new #treatments from discovery, to clinical development, and then to patients? The answer: an average of 10-15 years. That’s why we’re challenging conventional timelines to cut that process in half. Learn more: https://bit.ly/3yhUNOq
-
-
NEWS: American Society of Hematology's journal, Blood, published updated results from a Phase 3 study, which includes six-year follow-up data in #patients with previously untreated chronic lymphocytic leukemia (#CLL). Learn more about the findings: https://bit.ly/3LPPUPB [Video description: On-screen text reads, “Oncology News.”]
-
To celebrate our #interns' great work this summer, we hosted a picnic on National Intern Day at our North Chicago HQ. Explore our #internship opportunities and see why we were named to WayUp and Yello.co's list of Top 100 Internship Programs of 2024: https://bit.ly/3WNax5i #AbbVieLife [Video description: Six AbbVie interns jumping over the video frame to transition from their workspace to an outdoor picnic.]
Laman rakan sekutu
Laman yang serupa
Stok
ABBV
NYSE
Kelewatan 20 minit
USD 196.31
1.13 (0.579%)
- Buka
- 195.25
- Rendah
- 194.17
- Tinggi
- 196.5
Data daripada Refinitiv
Lihat maklumat lanjut diPendanaan
AbbVie
Jumlah 2 pusing
Lihat maklumat lanjut di crunchbase
Pusingan Terakhir
Hutang pasca IPO
Pautan Crunchbase Luaran untuk pusingan pendanaan terakhir
USD 15,000,000,000.00